Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 6:14 pm Purchase | 13G | Perspective Therapeutics Inc. CATX | Avidity Partners Management LP | 3,590,426 5.300% | 3,590,426 (New Position) | View |
| 2024-11-14 4:05 pm Purchase | 13G | Perspective Therapeutics Inc. CATX | COMMODORE CAPITAL LP | 3,350,000 4.960% | 3,350,000 (New Position) | View |
| 2024-11-14 10:24 am Purchase | 13G | Perspective Therapeutics Inc. CATX | JANUS HENDERSON GROUP PLC JHG | 4,799,352 7.100% | 4,799,352 (New Position) | View |
| 2024-11-08 2:17 pm Unchanged | 13G | Perspective Therapeutics Inc. CATX | BlackRock Inc. BLK | 4,039,974 6.000% | 0 (Unchanged) | View |
| 2024-11-07 09:24 am Purchase | 13G | Perspective Therapeutics Inc. CATX | FMR LLC | 9,496,225 14.083% | 3,991,403 (+72.51%) | View |
| 2024-11-07 09:12 am Purchase | 13G | Perspective Therapeutics Inc. CATX | FMR LLC | 5,504,822 8.164% | 5,504,822 (New Position) | View |
| 2024-10-24 2:02 pm Purchase | 13G | Perspective Therapeutics Inc. CATX | BlackRock Inc. BLK | 4,039,974 6.000% | 4,039,974 (New Position) | View |
| 2024-04-19 4:05 pm Purchase | 13G | Perspective Therapeutics Inc. CATX | COMMODORE CAPITAL LP | 38,906,673 6.600% | 38,906,673 (New Position) | View |
| 2024-03-08 11:22 am Purchase | 13D | Perspective Therapeutics Inc. CATX | Lantheus Holdings Inc. LNTH | 116,773,394 19.900% | 60,431,039 (+107.26%) | View |
| 2024-02-01 07:38 am Purchase | 13D | Perspective Therapeutics Inc. CATX | Lantheus Holdings Inc. LNTH | 56,342,355 10.740% | 56,342,355 (New Position) | View |
| 2023-09-18 9:20 pm Purchase | 13G | Perspective Therapeutics Inc. CATX | Schultz Michael K | 17,679,075 6.300% | 17,679,075 (New Position) | View |
| 2023-09-18 8:02 pm Purchase | 13G | Perspective Therapeutics Inc. CATX | Johnson Frances | 17,679,075 6.300% | 17,679,075 (New Position) | View |